A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Clinical trial NCT02624778 · COMPLETED

Trial details

NCT number: NCT02624778
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2015-12-22
Primary completion: 2019-08-28
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.